Table 2.
Summary of outcomes of in cats who completed treatment.
| GS-441524 (n = 48) | Molnupiravir (n = 52) | p-value | |
|---|---|---|---|
| Outcomes, n (%) | 1.000 a | ||
| Remission | 48 (100.0) | 51 (98.0) | |
| Death within 3 months of completion | 0 | 1 (1.9) | |
| Death after 3 months of completion | 1* | 0 | |
| Total days of administration, median (range) | 84 (84–192) | 84 (84–100) | 0.579 b |
| Values at the final treatment visit, mean (SD) | |||
| Weight, kg | 3.36 (0.803) | 3.56 (0.862) | 0.265 b |
| Temperature, °C | 38.37 (0.234) | 38.25 (0.366) | 0.237 b |
| Hematocrit, % | 39.63 (7.71) | 40.42 (8.27) | 0.651 b |
| Albumin/globulin ratio | 0.71 (0.132) | 0.69 (0.141) | 0.359 b |
*One cat, who had achieved remission and remained healthy at the 3-month post-treatment visit, later died from anemia 114 days after treatment completion.
a
Fisher’s exact text.
b
Mann-Whitney U test.